When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust into the limelight during the COVID-19 pandemic, but had been in ...

Add Yahoo as a preferred source to see more of our stories on Google. New AI model predicts mRNA protein output, aiding drug and vaccine design by targeting specific cells. (CREDIT: Science Photo ...

The federal government is cutting $500 million in research money for development of mRNA vaccines, which were widely used against the COVID-19 virus. Health Secretary Robert F. Kennedy Jr. said in a ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it lingers and causes harm, others say that idea just doesn’t hold up. A new ...

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials. When you purchase through links on ...

CAR T therapy has been transformative in the battle against deadly cancers. Scientists extract a patient’s own immune cells, genetically engineer them to target a specific type of cancer, and infuse ...

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior ...

Many people first learned about mRNA vaccines during the coronavirus pandemic, when the companies Pfizer-BioNTech and Moderna released their COVID-19 vaccines. The Pfizer-BioNTech shot was the first ...